JUSTIN JOHN: Open Payments
NPI 1104529890 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,482 in 73 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $70 · 2025 $1,482
Food & beverage: $1,482
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $224 |
| Madrigal Pharmaceuticals | 6 | $211 |
| Novo Nordisk Inc | 9 | $140 |
| GlaxoSmithKline, LLC. | 10 | $135 |
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| KYOWA KIRIN, INC. | 3 | $81 |
| Lilly USA, LLC | 4 | $78 |
| Gilead Sciences, Inc. | 3 | $68 |
| Corcept Therapeutics | 3 | $65 |
| Exact Sciences Corporation | 4 | $63 |
Products named: CAPLYTA, REZDIFFRA, TRELEGY ELLIPTA, CRYSVITA, AIRSUPRA, Rybelsus, Korlym, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
